The finding is significant because people can use CGM data to make dietary and lifestyle changes, which may be unnecessary, and the erroneously high readings (indicating glycaemia) could lead them to ...

In this Healio Video Exclusive, Caroline T. Nguyen, MD, speaks with Sarit Polsky, MD, MPH, about the use of continuous glucose monitoring for pregnant women with gestational diabetes and type 1 ...

The following is a summary of “Randomized Study Comparing Continuous Glucose Monitoring and Capillary Glucose Testing in Patients With Type 2 Diabetes After Hospital Discharge,” published in the March ...

Trinity Biotech, a commercial-stage biotech company focused on human diagnostics and diabetes management solutions, including wearable biosensors, has appointed Barclays Capital as its exclusive finan ...

A Japanese study conducted by a team from Nagoya University Graduate School of Medicine found that the use of continuous ...

In this rapidly growing digital era, healthcare is witnessing an unprecedented transformation through artificial intelligence ...

"This should be a wake-up call that research needs to be done that will inform creation of guidelines for clinical interpretation of CGM for patients without diabetes," says corresponding author ...

With substantial progress in developing its differentiated and innovative CGM and its significant market potential, Trinity Biotech’s board and management have determined that CGM technology and ...

Trinity Biotech (Nasdaq:TRIB) today announced the next stage of its transformation plan as it looks to bring a CGM to market.

Continuous Glucose Monitoring market poised for significant growth, driven by advancements in diabetes management and rising global prevalence.

A Japanese study has found that the use of continuous glucose monitoring (CGM) devices, equipped with sensors that alert diabetics when their blood sugar levels drop, can potentially make diabetic ...